FDA Inspection 1245241 — Los Angeles General Medical Center

Los Angeles General Medical Center — FEI 2015676

The FDA completed an inspection of Los Angeles General Medical Center on July 19, 2024 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)